Julie Jordan

Insider Reports History

Location
New York, NY
Signature
/s/ Donna M. Cochener, as attorney-in-fact for Julie Jordan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Julie Jordan:

Form 4 holding Chief Medical Officer

Homology Medicines, Inc.

Security class
Common Stock
Shares / value
7,496
Estimated value
$4,243
Report date
03 Aug 2023
Price
$0.5660
Ownership
Direct
Form 4 holding Chief Medical Officer

Neurogene Inc.

Security class
Employee Stock Option (Right to buy)
Shares / value
50,300
Estimated value
Report date
26 Mar 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Medical Officer

Neurogene Inc.

Security class
Stock Option (Right to Buy)
Shares / value
29,600
Estimated value
Report date
20 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Medical Officer

Homology Medicines, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
03 Aug 2023
Price
$1.15
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Julie Jordan

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .